Skip to primary content
Skip to secondary content

Biotech 365

Main menu

  • Biotech 365
  • Companies
  • Healthcare Investors
    • Healthcare LPs
  • Healthcare Investors Matchmaking
  • Free DEMO
  • Services
    • Preclinical Studies Database
    • Scientific Due Diligence
    • CRO & CDMO Database
  • Contact

Tag Archives: drug metabolism studies

XenoTech – drug metabolism studies

Posted on by

XenoTech is a biotech company providing in vitro drug metabolism and drug-drug interaction studies to pharmaceutical companies worldwide.

XenoTech – drug metabolism studies

xenotech

Continue reading →

Posted in Biotech Companies, Biotech Companies USA | Tagged accelerate drug development, ADME, BMO metabolite production kit, Christian Darabant, cytosol, David Buckley, Discovery Plus Screening Suite, DMPK, drug metabolism, drug metabolism studies, drug metabolism study, drug transporter, drug transporters, drug-drug interaction, drug-drug interactions, drug-metabolizing enzyme, drug-metabolizing enzymes, enzyme induction, enzyme inhibition, evaluating drug candidate, evaluating drug candidates, hepatocyte, hepatocytes, in vitro drug metabolism, in vivo ADME, Jason Neat, Joe Saitta, Kupffer cell, Kupffer cells, microsome, microsomes, P450 metabolite, P450 metabolites, P450 substrate, P450 substrates, subcellular fraction, Xeno Tech, XenoTech, XenoTech - drug metabolism studies, Yasuhiro Enomoto, Yasuhisa Adachi

        Services              Healthcare Investors Database              FAQs               CGU               Biotech & Pharma News             Contact
Proudly powered by WordPress